Advertisement
Targeted IL-1 blockers and CMR techniques allow more-tailored treatment strategies
Large cohort study argues for incorporating AF into perioperative risk scores
As the demographics of transplant recipients shift, their heart care must keep pace
Longer-term confirmation of VALOR-HCM could yield a noninvasive therapy for severe obstructive HCM
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
How Cleveland Clinic approaches the condition in the absence of randomized trial data
Why we favor a tailored approach to relieve LVOT obstruction
Long-overdue guidance now available on readiness to wean and device explant
A snapshot of our multisite experience in safely maintaining care during COVID-19
Three C Study suggests 28-day efficacy window, 600-mg dose
Nearly three-quarters found lacking in methodological quality and/or reporting practices
Advertisement
Advertisement